Approval · Notice of Compliance 3420 · 2003
DAYPRO: Notice of Compliance 3420
Issued October 9, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3420
- Date
- October 9, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anti-inflammatory analgesic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DAYPRO | 02027860 | Cancelled Post Market |
Medicinal ingredients
- OXAPROZIN 600 MG per TAB